{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Genotyping",
      "Next-generation sequencing",
      "RT-qPCR",
      "SARS-CoV-2",
      "Variants of concern"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37812919",
  "DateCompleted": {
    "Year": "2023",
    "Month": "12",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "10",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1159/000534067"
    ],
    "Journal": {
      "ISSN": "1423-0100",
      "JournalIssue": {
        "Volume": "66",
        "Issue": "1",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "Intervirology",
      "ISOAbbreviation": "Intervirology"
    },
    "ArticleTitle": "Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern.",
    "Pagination": {
      "StartPage": "136",
      "EndPage": "141",
      "MedlinePgn": "136-141"
    },
    "Abstract": {
      "AbstractText": [
        "The rapid emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and their potential to endangering the global health has increased the demand for a fast-tracking method in comparison to the next-generation sequencing (NGS) as a gold standard assay, particularly in developing countries. This study was designed to evaluate the performance of a commercial multiplex real-time PCR technique (GA SARS-CoV-2 OneStep RT-PCR Kit, Iran) for identification of SARS-CoV-2 variants of concern (VOCs) compared to the Oxford Nanopore NGS assay.",
        "A total of 238 SARS-CoV-2-positive respiratory samples from different waves of COVID-19 in Iran were randomly selected in this study. To determine the SARS-CoV-2 VOC, the samples were analyzed via the commercial triple target assay, GA SARS-CoV-2 OneStep RT-PCR Kit, and NGS as well.",
        "The results revealed good concordance between GA SARS-CoV-2 OneStep RT-PCR Kit and NGS for identification of SARS-CoV-2 VOCs. GA SARS-CoV-2 OneStep RT-PCR Kit identified Wuhan, Alpha, and Delta variants with 100% relative sensitivity and specificity. Regarding Omicron subvariants of BA.1, BA.2, and BA.4/5, the relative sensitivity of 100%, 100%, and 81.5% and the relative specificity of 95.3%, 93.5%, and 100% were observed.",
        "Overall, GA SARS-CoV-2 OneStep RT-PCR Kit can be used as a rapid and cost-effective alternative to NGS for identification of SARS-CoV-2 VOCs."
      ],
      "CopyrightInformation": "\u00a9 2023 The Author(s). Published by S. Karger AG, Basel."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran, zahraahmadii1995@gmail.com."
          }
        ],
        "LastName": "Ahmadi",
        "ForeName": "Zahra",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Influenza and Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Maleki",
        "ForeName": "Ali",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology and Biostatistics, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Eybpoosh",
        "ForeName": "Sana",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Fereydouni",
        "ForeName": "Zahra",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Tavakoli",
        "ForeName": "Mahsa",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Kashanian",
        "ForeName": "Setareh",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Farhan Asadi",
        "ForeName": "Laya",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Nemati",
        "ForeName": "Amir Hesam",
        "Initials": "AH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Research Center for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran."
          }
        ],
        "LastName": "Salehi-Vaziri",
        "ForeName": "Mostafa",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Intervirology",
    "NlmUniqueID": "0364265",
    "ISSNLinking": "0300-5526"
  },
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanopores"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Real-Time Polymerase Chain Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "High-Throughput Nucleotide Sequencing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    }
  ],
  "CoiStatement": "The authors declare that they have no conflict of interest related to this work."
}